Dynamic evolution of readmission risk factors across short-, medium-, and long-term horizons in type 2 diabetes: a machine learning-based predictive modeling study with SHAP interpretability - Scorecard - MDSpire

Dynamic evolution of readmission risk factors across short-, medium-, and long-term horizons in type 2 diabetes: a machine learning-based predictive modeling study with SHAP interpretability

  • By

  • Lei Li

  • Sheng Jiang

  • June 22, 2026

  • 0 min

Share

Clinical Scorecard: Evolving Readmission Risk Factors in Type 2 Diabetes: A Machine Learning Approach with SHAP Interpretability Over Short, Medium, and Long-Term Periods

At a Glance

CategoryDetail
ConditionType 2 Diabetes Mellitus (T2DM)
Key MechanismsDynamic evolution of readmission risk factors over time windows.
Target PopulationPatients with Type 2 Diabetes Mellitus (T2DM)
Care SettingSingle-center retrospective cohort study

Key Highlights

  • Nine machine learning models were developed to predict readmission at 30, 60, and 365 days.
  • Age was the primary predictor for 30-day readmission; inflammatory markers for 60-day; chronic complications for 365-day.
  • Artificial Neural Networks (ANN) showed the highest performance for short/medium-term predictions.
  • Random forest was effective for long-term prediction.
  • SHAP analysis provided insights into the dynamic nature of risk factors.

Guideline-Based Recommendations

Diagnosis

  • No specific predictive tools recommended for different time windows.

Management

  • Dynamic risk monitoring should be considered for T2DM patients.

Monitoring & Follow-up

  • Regular assessment of risk factors is essential as they evolve over time.

Risks

  • Readmission rates for T2DM patients are significantly higher than non-diabetic individuals.

Patient & Prescribing Data

14,048 hospitalized T2DM patients

Focus on individualized follow-up and intervention strategies based on evolving risk factors.

Clinical Best Practices

  • Utilize machine learning models for predicting readmission risk.
  • Incorporate SHAP analysis for understanding risk factor contributions.
  • Adapt clinical interventions based on the time-specific risk factors identified.

Related Resources & Content

Original Source(s)

Related Content